SC
FCSC

Saiers Capital’s Fibrocell Science Inc. FCSC Stock Holding History

Saiers Capital’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,697
Closed -$2K – 272
2014
Q1 		$2K Hold
1,697
– – ﹤0.01% 198
2013
Q4 		$1K Hold
1,697
– – ﹤0.01% 313
2013
Q3 		$2K Sell
1,697
-2,667
-61% -$216K ﹤0.01% 294
2013
Q2 		$70K Buy
+4,364
New +$361K 0.01% 227

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Saiers Capital's FCSC Position: Q2 2015 in Review

Saiers Capital sold out of Fibrocell Science Inc. (FCSC) in Q2 2015, closing a stake of 4,714 shares — an estimated $317K sold.

Saiers Capital first reported a position in FCSC in Q2 2013 and held it in 8 quarters. The position peaked at $433K in Q2 2013. 55 funds tracked by Wall St. Rank hold FCSC as of Q2 2015.

  • Saiers Capital reported no remaining Fibrocell Science Inc. position as of Q2 2015 after selling out during the quarter.
  • Saiers Capital sold 4,714 Fibrocell Science Inc. shares in Q2 2015, an estimated $317K.
  • Saiers Capital first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 8 quarters.
  • Saiers Capital's Fibrocell Science Inc. position peaked at $433K in Q2 2013.
  • 55 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2015.

Based on Saiers Capital's 13F filing for Q2 2015, filed 11 Aug 2015.